The following topics are covered in this special issue:
1: Genetics of Hepatocellular carcinoma in CHC
2: Epigenetics of Hepatocellular carcinoma in CHC
3: HCC incidence in CHC patients and the impact of achieving SVR
4: Impact of DAAs on the recurrence of HCC in CHC patients
5: Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals
6: HCC risk stratification in CHC patients following viral clearance
7: HCC in non-cirrhotic CHC patients
8: Fibrosis changes following viral clearance and its relation to HCC
9: HCC surveillance in compensated advanced chronic liver disease (cACLD)
1. Gamal Shiha Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. 2. Reham Soliman Tropical Medicine Department, Faculty of Medicine, Port Said University, Port Said, Egypt. 3. Mohammed Eslam Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia. 4. Francesco Negro Divisions of Gastroenterology and Hepatology, Geneva University Hospitals, Geneva, Switzerland. 5. Dina Attia Department of Gastroenterology, Hepatology and Endemic Medicine, Faculty of Medicine, Beni Suef University, Egypt. 6. Nevin Yılmaz Transplant Hepatology, Mugla University School of Medicine, Mugla, Turkey. 7. Yasser Fouad Department of Endemic Medicine and Gastroenterology, Faculty of Medicine, Minia University, Egypt.
The list is arranged in no particular order and being updated.